Persistent Staphylococcus aureus bacteremia and 30-day mortality: a systematic review and meta-analysis
- 1Division of Infectious Diseases (Department of Internal Medicine), All India Institute of Medical Sciences, Jodhpur, 342005 India
- 2Department of Infectious Diseases, Indus International Hospital, Mohali, India
Abstract
Background: A substantial proportion of patients with Staphylococcus aureus bacteremia (SAB) continue to have persistent culture positivity. However, the magnitude and consistency of its association with mortality remain uncertain.
Methods: Data were extracted from PubMed/MEDLINE, Embase, Scopus, and the Cochrane Library from inception to January 2026. Observational studies comparing 30-day all-cause mortality between S. aureus persistent and non-persistent bacteremia were included. Persistent bacteremia was defined as continued positivity of blood cultures for S. aureus for ≥ 48 h after initiation of appropriate antimicrobial therapy. Risk of bias and quality were evaluated with the ROBINS-E tool. Pooled odds ratios (ORs) for 30-day mortality were estimated using a random-effects meta-analysis model. Heterogeneity was investigated through subgroup analyses, sensitivity analyses, and meta-regression.
Results: Nineteen studies comprising 7,993 patients with SAB met the inclusion criteria. In pooled unadjusted analysis, persistent bacteremia was associated with increased 30 day all-cause mortality (OR 1.97, 95% CI 1.62–2.40, I2 = 34%). Adjusted mortality data accounting for additional patient characteristics were available from 9 studies (5,775 patients), and revealed a similar increased mortality rate in persistent bacteremia compared to non-persistent bacteremia (OR 2.81, 95% CI 1.59–4.96, I2 = 91%). Meta-regression showed no significant influence of age, proportion of methicillin-resistant S. aureus, or hospital-acquired infection on the pooled mortality. No evidence of publication bias was detected.
Conclusions: In this meta-analysis, patients with S. aureus persistent bacteremia had a higher mortality risk than those with non-persistent bacteremia. Future research should target this high-risk phenotype to improve outcomes in SAB.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13643-026-03289-5.
Related
- Persistent Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia Due to Pelvic Pyomyositis and Abscesses With Extension Through the Sciatic Notch: A Case Report.
- Factors associated with mortality in Staphylococcus aureus bacteremia: the role of infectious diseases consultation
- Cefazolin versus Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia
- Cefazolin vs Antistaphylococcal Penicillins for Methicillin-Susceptible Staphylococcus aureus Bacteremia—Convergence of Observational and Randomized Evidence
BibTeX
@article{meena2026persistent,
title = {{Persistent Staphylococcus aureus bacteremia and 30-day mortality: a systematic review and meta-analysis}},
author = {Durga Shankar Meena and Deepak Kumar and Navneet Kaur and Gopal Krishana Bohra},
journal = {Systematic Reviews},
year = {2026},
month = aug,
doi = {10.1186/s13643-026-03289-5},
url = {https://doi.org/10.1186/s13643-026-03289-5},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Persistent Staphylococcus aureus bacteremia and 30-day mortality: a systematic review and meta-analysis
AU - Durga Shankar Meena
AU - Deepak Kumar
AU - Navneet Kaur
AU - Gopal Krishana Bohra
PY - 2026
DA - 2026/08/12
JO - Systematic Reviews
DO - 10.1186/s13643-026-03289-5
UR - https://doi.org/10.1186/s13643-026-03289-5
AB - Background: A substantial proportion of patients with Staphylococcus aureus bacteremia (SAB) continue to have persistent culture positivity. However, the magnitude and consistency of its association with mortality remain uncertain. Methods: Data were extracted from PubMed/MEDLINE, Embase, Scopus, and the Cochrane Library from inception to January 2026. Observational studies comparing 30-day all-cause mortality between S. aureus persistent and non-persistent bacteremia were included. Persistent bacteremia was defined as continued positivity of blood cultures for S. aureus for ≥ 48 h after initiation of appropriate antimicrobial therapy. Risk of bias and quality were evaluated with the ROBINS-E tool. Pooled odds ratios (ORs) for 30-day mortality were estimated using a random-effects meta-analysis model. Heterogeneity was investigated through subgroup analyses, sensitivity analyses, and meta-regression. Results: Nineteen studies comprising 7,993 patients with SAB met the inclusion criteria. In pooled unadjusted analysis, persistent bacteremia was associated with increased 30 day all-cause mortality (OR 1.97, 95% CI 1.62–2.40, I2 = 34%). Adjusted mortality data accounting for additional patient characteristics were available from 9 studies (5,775 patients), and revealed a similar increased mortality rate in persistent bacteremia compared to non-persistent bacteremia (OR 2.81, 95% CI 1.59–4.96, I2 = 91%). Meta-regression showed no significant influence of age, proportion of methicillin-resistant S. aureus, or hospital-acquired infection on the pooled mortality. No evidence of publication bias was detected. Conclusions: In this meta-analysis, patients with S. aureus persistent bacteremia had a higher mortality risk than those with non-persistent bacteremia. Future research should target this high-risk phenotype to improve outcomes in SAB. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s13643-026-03289-5.
SN - 2046-4053
ER -